MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-BR-23-0043522
Malay Pharma Private Limited
Malay Pharma Private Limited - paper in Patna, Bihar, India. Directors, charges & compliance details.
Revenue · FY 2025
₹2.25 Cr
▲ 1457% YoY
Net profit · FY 2025
₹2.36 Lakh
Net margin 1%
EBITDA · FY 2025
₹16.79 Lakh
EBITDA margin 7.5%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹1.38 Cr
Secured borrowings
Company age
3 yrs
Est. 2023
Directors on board
3
As per MCA filings
About Malay Pharma Private Limited
Data last updated:
Malay Pharma Private Limited is a private limited company based in Patna, Bihar, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 16 March 2023.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U21002BR2023PTC062024.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Ritwik Singh (Managing Director) and Ragini Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Patna, Bihar.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.25 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.36 Lakh (net margin 1%) and EBITDA of ₹16.79 Lakh (EBITDA margin 7.5%).
As per MCA filings, the company has open charges of ₹1.38 Cr on record.
Malay Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-23-0043522).
Company details
CIN U21002BR2023PTC062024
Registration Number 062024
Incorporation Date 16 March 2023
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-BR-23-0043522
Recognitions & Rankings of Malay Pharma
Contact details
Malay Pharma Private Limited's registered office is in Patna, Bihar.
- Registered AddressF No. – 407 Panday Mall Com., Fraser Road Maurya Lok, Patna, Bihar, India – 800001
- IndustryPaper, Paper & Paper Products, Manufacturing
Comprehensive company report
Malay Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Malay Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Malay Pharma Private Limited, buy the company report.
Financials of Malay Pharma Private Limited
FY 2025 filings availableMalay Pharma Private Limited reported revenue of ₹2.25 Cr (up 1457% YoY) for FY 2025.
Revenue · FY 2025
₹2.25 Cr ▲ 1457%
Net profit · FY 2025
₹2.36 Lakh margin 1%
EBITDA · FY 2025
₹16.79 Lakh margin 7.5%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹16.79 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2.36 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 7.5% | ||
| Net Profit Margin | 1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Malay Pharma Private Limited, buy the company report.
Board of directors of Malay Pharma Private Limited
Malay Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ragini Rani | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Arun Kumar Singh | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Ritwik Singh Also directs: Securebyte Cyber Solutions Private Limited | Managing Director | 16 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Malay Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sant Oil Associates Private Limited | ₹2.25 Cr (FY 2025) | 6902.0% | New Delhi, Delhi, India | |||
| Link Bell Private Limited | ₹2.25 Cr (FY 2025) | -32.0% | New Delhi, Delhi, India | |||
| Fruitmark Impex Private Limited | ₹2.25 Cr (FY 2025) | 267.0% | Nilambur, Kerala, India | |||
| Satyam Shivam Enterprises Private Limited | ₹2.25 Cr (FY 2025) | 400.0% | Delhi, India | |||
| Nec New Era Collection Private Limited | ₹2.25 Cr (FY 2024) | 26.0% | Amritsar, Punjab, India | |||
| Malay Pharma Private Limitedthis company | ₹2.25 Cr (FY 2025) | ₹2.36 Lakh | 1% | 1457.0% | Patna, Bihar, India | |
| Shar-Lee Filtorites Pvt Ltd | ₹2.25 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Ys Securities Private Limited | ₹2.25 Cr (FY 2025) | 177.0% | New Delhi, Delhi, India | |||
| Zespri International (India) Private Limited | ₹2.25 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Chemeast India Private Limited | ₹2.24 Cr (FY 2024) | 19.0% | Delhi, India | |||
| Sheth Investments and Trading Company Private Limited | ₹2.24 Cr (FY 2025) | -6.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Malay Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.38 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2024 | 100935055 | State Bank of India | ₹1.38 Cr | Open |
To see the full charge records of Malay Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Malay Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Malay Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Malay Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Malay Pharma Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Arun Kumar Singh was appointed as Director on 16 Mar 2023.
AGM
Malay Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 138.00 Lakh registered on 30 May 2024 with Charge ID 100935055 was modified on 26 Aug 2025.
Filing
Malay Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Charges
A charge with State Bank Of India amounted to Rs. 138.00 Lakh with Charge ID 100935055 was registered on 30 May 2024.
Appointed
Arun Kumar Singh was appointed as Director.
Appointed
Ragini Rani was appointed as Director.
Appointed
Ritwik Singh was appointed as Managing Director.
Incorporation
16 Mar 2023
Malay Pharma Private Limited was registered on 16 Mar 2023 with Roc Patna & aged 3 years 7 months as per MCA records.
Frequently asked questions
Malay Pharma is an active private limited company based in Patna, Bihar, India. The company works in paper and paper products, within the paper industry. It was incorporated on 16 March 2023 (3+ years old) and is registered under CIN U21002BR2023PTC062024.
Malay Pharma has 3 current directors:
- Ritwik Singh - Managing Director
- Ragini Rani - Director
- Arun Kumar Singh - Director
The latest financial statements of Malay Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Malay Pharma is U21002BR2023PTC062024. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Malay Pharma was incorporated on 16 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Malay Pharma by revenue are Sant Oil Associates Private Limited, Link Bell Private Limited, Fruitmark Impex Private Limited, Satyam Shivam Enterprises Private Limited, Nec New Era Collection Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Arun Kumar Singh was appointed as Director on 16 Mar 2023. Ragini Rani was appointed as Director on 16 Mar 2023. Ritwik Singh was appointed as Managing Director on 16 Mar 2023.
Yes, Malay Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-23-0043522).
The registered office of Malay Pharma is at F No. – 407 Panday Mall Com., Fraser Road Maurya Lok, Patna, Bihar, India – 800001.
Malay Pharma operates in the paper industry, in the paper and paper products segment.
Malay Pharma has open charges of ₹1.38 Cr and no satisfied charges on record as per latest MCA filings.